Garfield Alastair: insider trades.
Garfield Alastair reported 6 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 4 sales ($913K), across 1 company.
- Transactions
- 6
- Purchases (P)
- 0
- Sales (S)
- 4
- Companies
- 1
- Name as filed
- Garfield Alastair
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Rhythm Pharmaceuticals, Inc. (RYTM) | Officer · Chief Scientific Officer | 6 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-13 | Rhythm Pharmaceuticals, Inc. | S | 1,556 | $117.08 | 6,495 | Form 4 |
| 2026-08-13 | Rhythm Pharmaceuticals, Inc. | S | 800 | $119.17 | 2,295 | Form 4 |
| 2026-08-13 | Rhythm Pharmaceuticals, Inc. | S | 2,007 | $116.11 | 8,051 | Form 4 |
| 2026-08-13 | Rhythm Pharmaceuticals, Inc. | S | 3,400 | $118.28 | 3,095 | Form 4 |
| 2026-07-01 | Rhythm Pharmaceuticals, Inc. | M | 4,445 | — | 12,208 | Form 4 |
| 2026-07-01 | Rhythm Pharmaceuticals, Inc. | F | 2,150 | $110.41 | 10,058 | Form 4 |
Questions
What stock did Garfield Alastair buy or sell?
Garfield Alastair reported 6 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 4 sales ($913K), across 1 company.
Is Garfield Alastair the same person as other filers with this name?
This page covers SEC CIK 2027261 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/garfield-alastair-2027261.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.